Miglena Marinova Achkar | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Researcher Information
Affiliation Medical University Varna
Country Bulgaria
Scopus ID 57739433300
Documents 3
Citations 33
h-index 2
Subject Area Medicine
Event Scientific World Research Awards

Miglena Marinova Achkar

Medical University Varna, Bulgaria

Miglena Marinova Achkar is affiliated with Medical University Varna, Bulgaria, and has contributed to medical research focusing on pediatric allergy, environmental determinants of disease, and preventive healthcare. Her scholarly publications demonstrate an evidence-based approach to clinical medicine and public health, making her profile relevant for recognition through the Scientific World Research Awards.[1]

Abstract

This article summarizes the academic profile of Miglena Marinova Achkar, highlighting scholarly activities in medicine, pediatric allergy, and environmental health research. Available publication metrics and research outputs indicate contributions supporting evidence-based healthcare and preventive medicine while demonstrating suitability for academic recognition.[1]

Keywords

Medicine, Pediatrics, Allergy, Environmental Health, Atopy, Child Health, Epidemiology, Preventive Medicine, Clinical Research, Bulgaria

Introduction

Miglena Marinova Achkar’s research focuses on pediatric medicine and allergic diseases, emphasizing environmental influences on childhood health. Her published studies contribute valuable clinical observations supporting preventive healthcare strategies and encourage evidence-based decision-making for physicians, researchers, and healthcare policymakers.[1]

Research Profile

Her Scopus profile includes peer-reviewed publications addressing pediatric allergy and environmental determinants affecting children’s health. With measurable citations and an established h-index, her academic record reflects participation in internationally indexed research contributing to contemporary medical knowledge.[1]

Research Contributions

Her investigations examine relationships between environmental exposures and allergic conditions among children with hereditary susceptibility. These findings provide clinically relevant evidence supporting early prevention, risk assessment, and improved understanding of pediatric allergic disease development within healthcare practice.[1]

Publications

Published research includes studies investigating environmental determinants of allergic diseases in children, emphasizing epidemiological evaluation and clinical interpretation. These peer-reviewed publications contribute reliable scientific evidence supporting pediatric medicine, allergy prevention, and public health research initiatives.[1]

Research Impact

Citation metrics indicate that her work has attracted scholarly attention within pediatric and allergy research communities. The research supports ongoing investigations into childhood allergic diseases and contributes useful evidence for improving preventive healthcare and clinical management practices.[1]

Award Suitability

Her documented research achievements, peer-reviewed publications, citation record, and commitment to pediatric medical science demonstrate qualities aligned with the objectives of the Scientific World Research Awards. The profile reflects meaningful academic contributions deserving consideration for research recognition.[1]

Conclusion

Miglena Marinova Achkar has established an emerging academic profile through research addressing pediatric allergy and environmental health. Her publications, citations, and evidence-based investigations contribute to medical science while supporting continued scholarly development and international academic recognition.[1]

 

References

  1. Early-Life Environmental Determinants of Allergic Conditions in Children with Atopic Heredity: A Single Center Cross-Sectional Study from Bulgaria.
    https://www.mdpi.com/2076-3271/13/3/198
  2. Elsevier. (n.d.). Scopus author details: Miglena Marinova Achkar, Author ID 57739433300. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57739433300
  3. Scientific World Research Awards. (n.d.). Scientific World Research Awards.
    https://scientificworld.net/

Hamid Safarzadeh | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Hamid Safarzadeh
Affiliation University of Palermo
Country Italy
Scopus ID 57811418200
Documents 24
Citations 38
h-index 3
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0001-5108-2104

Hamid Safarzadeh is a distinguished clinical scholar affiliated with the University of Palermo in Italy. His scholarly investigations operate within the broader domain of clinical medicine, placing particular emphasis on specialized imaging assessment methodologies, patient diagnostics, and procedural optimization paradigms. Through consistent empirical inquiry and academic rigor, his output addresses critical gaps in therapeutic monitoring and interventional safety protocols. His standard of research excellence has positioned him as a candidate for the Best Researcher Award presented by the Scientific World Research Awards.

1. Abstract

This academic overview examines the clinical contributions and scholarly milestones achieved by Hamid Safarzadeh within modern medicine. Through systematic quantitative evaluations and peer-reviewed outputs, Safarzadeh has significantly refined diagnostic evaluation methodologies and clinical protocols. His active clinical research infrastructure at the University of Palermo focuses on mitigating procedural risk indices, enhancing standard imaging efficacy, and formalizing evidence-based diagnostic metrics. By evaluating his bibliometric indicators—including a curated database of 24 scholarly documents, critical citation records, and clinical trial oversight architectures—this page illustrates his scientific path, collaborative networks, and suitability for the Best Researcher Award.

2. Keywords

Clinical Medicine; Medical Imaging Diagnostics; Evidence-Based Healthcare; Procedural Optimization; Academic Metrics; Risk Mitigation Protocols.

3. Introduction

Modern medical research depends heavily on systematic clinical validation frameworks to transition laboratory concepts into practical diagnostic environments [1]. Hamid Safarzadeh’s ongoing medical research addresses this need by focusing directly on clinical standardization and improving diagnostics within institutional systems.

4. Research Profile

Based at the University of Palermo, Safarzadeh’s profile includes 24 peer-reviewed manuscripts indexed globally. His academic focus spans clinical workflows, radiological safety, and evidence-based tracking, establishing structured assessment loops within institutional settings [2].

5. Research Contributions

Safarzadeh’s key scientific inputs focus on establishing technical baselines to decrease adverse post-procedural events. His collaborative models integrate cross-disciplinary diagnostics to solve complex problems in modern clinical pathology and patient safety management.

6. Publications

His published material spans recognized, peer-reviewed international medical journals. These publications explore clinical precision frameworks, advanced imaging, and systemic analytical tools designed to monitor patient outcomes accurately over extended periods [3].

7. Research Impact

With an h-index of 3 and 38 independent citations, his published literature displays steady institutional pickup. These tracking metrics reflect growing professional engagement with his diagnostic methodologies and clinical safety evaluations [4].

8. Award Suitability

Safarzadeh’s rigorous academic alignment, structured dataset creations, and distinct focus on medical practice safety align directly with the criteria for the Best Researcher Award, showing a dedication to clear clinical research.

9. Conclusion

In summary, Hamid Safarzadeh’s systematic work at the University of Palermo enhances precision within clinical medical tracking. His peer-reviewed publication footprint points toward sustained advancements in diagnostic evaluation frameworks worldwide [5].

11. References

  1. Elsevier. (n.d.). Scopus author details: Hamid Safarzadeh, Author ID 57811418200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=57811418200

  2. Pugliesi, R. A., Muna, S. F., Mahnken, A. H., Maalouf, N., Chatzis, G., & Apitzsch, J. (2026). Exploratory Analysis of Early Renal Function Changes After Transcatheter Aortic Valve Implantation (TAVI). Journal of Clinical Medicine, 15(10), 3726.

    https://doi.org/10.3390/jcm15103726

  3. Pugliesi, R. A., Maalouf, N., Gullo, G., Mahnken, A. H., & Apitzsch, J. (2026). Pulmonary Hemorrhage and Pneumothorax Risk During CT-Guided Lung Biopsy for Suspected Lung Cancer. Cancers, 18(5), 0743.

    https://doi.org/10.3390/cancers18050743

  4. Pugliesi, R. A., Ben Mansour, K., Apitzsch, J., Papachristodoulou, A., Rafailidis, V., & Katz, D. S. (2025). Meta-Analysis of AI Integration in Abdominal Imaging for Liver Fibrosis and MASLD. Journal of Clinical Medicine, 14(23), 8466.

    https://doi.org/10.3390/jcm14238466

  5. Pugliesi, R. A., Nasser, Y., Benchekroun, A., BenAyed, R., Mahnken, A. H., Maalouf, N., & Apitzsch, J. (2025). Impact of Technical Standardization on Pneumothorax and Chest Tube Insertion Rates. Journal of Clinical Medicine, 14(14), 4838.

    https://doi.org/10.3390/jcm14144838

Taraneh Yazdanparast | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Taraneh Yazdanparast

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences

Taraneh Yazdanparast
Affiliation Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
Country Iran
Scopus ID 55604155600
Documents 39
Citations 328
h-index 11
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0003-3310-5653

Taraneh Yazdanparast, affiliated with the Center for Research and Training in Skin Diseases and Leprosy at Tehran University of Medical Sciences, is recognized for scholarly contributions within the field of medicine. Her research portfolio demonstrates sustained engagement in dermatological and clinical investigations, reflected through peer-reviewed publications, citation impact, and international academic visibility. The Best Researcher Award acknowledges research excellence, scientific productivity, and contributions to advancing medical knowledge through evidence-based studies and interdisciplinary collaboration.[1][2]

Abstract

The Best Researcher Award recognizes Taraneh Yazdanparast for her contributions to medical science, particularly within dermatology and related clinical research disciplines. Her scholarly activities encompass the development, evaluation, and dissemination of evidence-based findings that support improved understanding of skin diseases and patient care. Through peer-reviewed publications, collaborative investigations, and academic engagement, she has contributed to the advancement of scientific knowledge while maintaining a measurable research impact. Bibliometric indicators, including publication output, citation performance, and research visibility, demonstrate a sustained commitment to scholarly excellence and continued contributions to the international medical research community.[1][2]

Keywords

Best Researcher Award, Taraneh Yazdanparast, Medicine, Dermatology Research, Clinical Studies, Tehran University of Medical Sciences, Scientific Excellence, Research Impact, Citation Analysis, Academic Recognition.

Introduction

Recognition through academic awards highlights the importance of sustained scientific achievement and knowledge dissemination. Researchers working within medical sciences contribute to improved healthcare outcomes through rigorous investigation and publication of findings. Taraneh Yazdanparast’s research activities exemplify these objectives by supporting scientific inquiry and advancing evidence-based understanding in dermatological and clinical medicine.[1]

Research Profile

Taraneh Yazdanparast is affiliated with the Center for Research and Training in Skin Diseases and Leprosy at Tehran University of Medical Sciences. Her academic profile demonstrates consistent engagement in medical research, supported by a documented publication record, international indexing, and measurable citation performance. Her work reflects active participation in scholarly communication and collaborative scientific investigations.[2]

Research Contributions

Research contributions associated with Taraneh Yazdanparast include investigations related to dermatological disorders, clinical management strategies, patient outcomes, and evidence-based healthcare practices. Her publications contribute to the scientific literature by addressing relevant medical challenges and expanding knowledge available to clinicians, researchers, and healthcare professionals engaged in skin disease research and treatment.[3]

Publications

The researcher has produced a portfolio of scholarly publications indexed in major academic databases. These publications encompass peer-reviewed articles and collaborative studies that contribute to the dissemination of scientific knowledge. The documented publication record supports visibility within the international research community and demonstrates continued academic productivity over time.[1][4]

Research Impact

Research impact can be evaluated through publication output, citation metrics, and scholarly influence. With 39 indexed documents, 328 citations, and an h-index of 11, the available indicators suggest meaningful engagement with the academic community. These metrics provide evidence of research visibility and demonstrate the relevance of published work within the broader field of medicine.[1]

Award Suitability

The Best Researcher Award is intended to recognize individuals who demonstrate excellence in research productivity, scientific quality, and contribution to knowledge advancement. Taraneh Yazdanparast’s publication record, citation performance, and sustained commitment to medical research align with these criteria. Her academic achievements support her suitability for recognition within international research award programs.[5]

Conclusion

Taraneh Yazdanparast has established a notable academic presence through contributions to medicine and dermatological research. Her scholarly output, research influence, and commitment to scientific inquiry demonstrate the qualities associated with distinguished research achievement. Recognition through the Best Researcher Award reflects the significance of her work and its contribution to the advancement of medical science and academic excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Taraneh Yazdanparast, Author ID 55604155600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55604155600
  2. ORCID. (n.d.). Research profile of Taraneh Yazdanparast.
    https://orcid.org/0000-0003-3310-5653
  3. Yazdanparast, T., et al. (2018). Biophysical and ultrasonographic changes in lichen planus compared with uninvolved skin. The Journal of Dermatology.
    https://doi.org/10.1111/1346-8138.17824
  4. Google Scholar. (n.d.). Scholar profile and citation metrics of Taraneh Yazdanparast.
    https://scholar.google.com/citations?user=3sVlyLQAAAAJ&hl=en&oi=ao
  5. Scientific World Research Awards. (n.d.). Best Researcher Award evaluation and recognition framework.
    https://scientificworld.net/

Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Lina Posada Calderon | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Dr. Lina Posada Calderon | Medicine | Research Excellence Award

Resident | New York Presbyterian | United States

Dr. Lina Posada Calderon is an accomplished biomedical researcher at Weill Cornell Medicine, New York, specializing in translational and molecular cancer research. Her work focuses on the clinical and molecular characterization of cancers, precision oncology, biomarker discovery, and genetic drivers of tumor progression, with particular emphasis on KRAS-mutated malignancies. She has strong expertise in molecular biology, cancer genomics, clinical data analysis, interdisciplinary research, and high-impact scientific publishing. Her research bridges laboratory discoveries with patient-centered clinical outcomes. Dr. Posada Calderon has published 12 Scopus-indexed documents, receiving 61 citations, and holds an h-index of 5, reflecting her growing scholarly impact and emerging leadership in precision cancer research.

 

Citation Metrics (Scopus)

61
45
30
15
0

Citations

61

Documents

12

h-index

5

Citations

Documents

h-index

View Scopus Profile
 View Google Scholar

Featured Publications

 

Philipp Kanske | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Philipp Kanske | Medicine | Research Excellence Award

Professor | TUD Dresden University of Technology | Germany

Prof. Dr. Philipp Kanske is an internationally recognized expert in cognitive and affective neuroscience whose work bridges psychology, social cognition, neuroimaging, and mental health research. His research centers on empathy, compassion, emotion regulation, personality functioning, and the neurobiological mechanisms that shape human social behavior across the lifespan. He investigates how individuals perceive and respond to others’ emotions, how empathic stress is transmitted within families, and how interventions such as meditation and compassion training can induce functional neural plasticity and improve emotional well-being, particularly in older adults. His interests extend to personality organization in both clinical and non-clinical populations, disease progression in bipolar disorder, white-matter microstructure, attachment dynamics in couples, value integration for self and others, and ritual-based methods for strengthening human–nature connectedness in the context of sustainability transformations. Prof. Kanske is skilled in a wide range of methodologies including experimental psychology, behavioral analysis, longitudinal study design, cognitive testing, psychoneuroendocrinology, structural and functional MRI, and advanced statistical modeling. His contributions to research transparency and reproducibility are reflected in his leadership in developing the PECANS methodological framework for cognitive and neuropsychological studies. Throughout his career, he has received multiple awards and honors (as listed in Scopus’s “Awarded Grants” section), recognizing his innovative contributions to social neuroscience, aging research, and clinical psychology. According to Scopus Preview, he has 7,136 citations, 163 documents, and an impressive h-index of 43, underscoring his global scientific influence and sustained scholarly productivity. Overall, Prof. Dr. Philipp Kanske’s work provides significant insights into how emotional, neural, and relational processes shape human behavior, offering important implications for mental health, interpersonal functioning, and societal well-being, and solidifying his role as a leading figure in modern neuroscience and psychology.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Kanske, P., Heissler, J., Schönfelder, S., Bongers, A., & Wessa, M. (2011). How to regulate emotion? Neural networks for reappraisal and distraction. Cerebral Cortex, 21(6), 1379–138.
    Citations: 698

  2. Schurz, M., Radua, J., Tholen, M. G., Maliske, L., Margulies, D. S., Mars, R. B., … Kanske, P. (2021). Toward a hierarchical model of social cognition: A neuroimaging meta-analysis and integrative review of empathy and theory of mind. Psychological Bulletin, 147(3), 293–. Citations: 648

  3. Kanske, P., & Kotz, S. A. (2007). Concreteness in emotional words: ERP evidence from a hemifield study. Brain Research, 1148, 138–148. Citations: 630

  4. Preckel, K., Kanske, P., & Singer, T. (2018). On the interaction of social affect and cognition: Empathy, compassion and theory of mind. Current Opinion in Behavioral Sciences, 19, 1–6.
    Citations: 554

  5. Moshontz, H., Campbell, L., Ebersole, C. R., IJzerman, H., Urry, H. L., Forscher, P. S., … Kanske, P. (2018). The Psychological Science Accelerator: Advancing psychology through a distributed collaborative network. Advances in Methods and Practices in Psychological Science, 1(4), 501–515. Citations: 499

Prof. Dr. Philipp Kanske’s work advances global scientific understanding of empathy, compassion, and emotion regulation by uncovering the neural and psychological mechanisms that drive healthy social functioning. His research enables evidence-based mental-health interventions, strengthens human well-being across communities, and supports interdisciplinary innovation in neuroscience, clinical psychology, aging research, and societal resilience.

 

Dimitrios Tsiachris | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Manouchehr Ashrafpour | Medicine | Best Scholar Award

Published on by Scientific World Research Awards

Dr. Manouchehr Ashrafpour | Medicine | Best Scholar Award

Faculty Member | Babol University of Medical Sciences | Iran

Dr. Manouchehr Ashrafpour is a prominent neuroscientist and biomedical researcher at Babol University of Medical Sciences, renowned for his extensive contributions to neuropharmacology, molecular neuroscience, and neurodegenerative disease research. He earned his advanced degrees in medical sciences and neuroscience, building a strong academic foundation that bridges cellular biology and clinical neurotherapeutics. Throughout his professional career, Dr. Ashrafpour has demonstrated exceptional expertise in experimental neurobiology, drug delivery systems, and the molecular mechanisms underlying brain disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. His research primarily focuses on the neuroprotective effects of natural bioactive compounds and nanotechnology-based formulations, including curcumin-, piperine-, arbutin-, and quercetin-loaded nanoparticles, which have shown promising results in reducing oxidative stress, glial activation, and neuronal degeneration. He possesses advanced research skills in animal modeling, histopathological assessment, biochemical analysis, neurobehavioral testing, and nanomedicine formulation, complemented by a strong command of cellular electrophysiology and molecular signaling studies. His professional experience encompasses collaborations with leading neuroscientists on projects exploring the role of vitamins, antioxidants, and receptor modulation (notably adenosine A2A receptor blockade) in promoting neural repair and functional recovery. Dr. Ashrafpour’s scholarly achievements are reflected in his strong Scopus record, which includes over 700 citations, numerous peer-reviewed documents, and an h-index of 17, underscoring his global academic influence. He has received recognition and academic honors for his innovative work in neurotherapeutic discovery and translational neuroscience, highlighting his commitment to improving treatment strategies for neurodegenerative diseases. In conclusion, Dr. Manouchehr Ashrafpour stands as a distinguished figure in contemporary neuroscience, whose multidisciplinary approach—spanning nanotechnology, pharmacology, and neurobiology—continues to shape the future of neuroprotective medicine and inspire emerging researchers in biomedical sciences worldwide.

Profiles: ORCID | Google Scholar 

Featured Publications

  1. Naeimi, R., Safarpour, F., Hashemian, M., Tashakorian, H., Ahmadian, S. R., & Ashrafpour, M. (2018). Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum. Neuroscience Letters, 674, 1–10. Cited by 71.

  2. Mansoor, S. R., Hashemian, M., Khalili-Fomeshi, M., Ashrafpour, M., & Moghadamnia, A. A. (2018). Upregulation of klotho and erythropoietin contributes to the neuroprotection induced by curcumin-loaded nanoparticles in an experimental model of chronic epilepsy. Brain Research Bulletin, 142, 281–288. Cited by 52.

  3. Khalili-Fomeshi, M., Azizi, M. G., Esmaeili, M. R., Gol, M., Kazemi, S., & Ashrafpour, M. (2018). Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus. Behavioural Brain Research, 337, 131–138. Cited by 49.

  4. Dastan, Z., Pouramir, M., Ghasemi-Kasman, M., Ghasemzadeh, Z., Dadgar, M., & Ashrafpour, M. (2019). Arbutin reduces cognitive deficit and oxidative stress in an animal model of Alzheimer’s disease. International Journal of Neuroscience, 129(11), 1145–1153. Cited by 45.

  5. Dadgar, M., Pouramir, M., Dastan, Z., Ghasemi-Kasman, M., & Ashrafpour, M. (2018). Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson’s disease. Avicenna Journal of Phytomedicine, 8(6), 533–540. Cited by 43.